| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |